Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker

Background: Recent studies have identified that transglutaminases (TGMs) are involved in a widespread epigenetic modification in tumorigenesis. However, it remains unclear how transglutaminase 3 (TGM3) affects in pan-cancer. The present study aimed to explore the clinical and prognostic function of...

Full description

Bibliographic Details
Main Authors: Wenqing Zhang, Chenglong Wu, Kaili Zhou, Yu Cao, Wange Zhou, Xue Zhang, Dan Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Genetics
Subjects:
TGM3
immunotherapy
immune response
prognosis
pan-cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.993438/full

Similar Items

Similar Items